Few women willing to use AstraZeneca’s Nolvadex, study shows
The study, published in CANCER, a peer-reviewed journal of the American Cancer Society, reports that concerns over the drug’s adverse effects were the primary reason for refusal. Tamoxifen,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.